For example, ZDHHC9-mediated PD-L1 palmitoylation has been indicated to stabilize PD-L1 protein levels in tumor cells, thereby promoting the efficacy of immune checkpoint inhibitors. Here, ZDHHC9 is linked to neoplasm.